- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Slideshow
Joint AAD, NPF phototherapy guidelines
Author(s):
Discover key takeaways from the American Academy of Dermatology and National Psoriasis Foundation joint guidelines for the management and treatment of psoriasis with phototherapy published in the September issue of the Journal of American Academy of Dermatology.
References:
Elmets, Craig A., et al. Joint American Academy of DermatologyâNational Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019;81(3):775â804
(Sweetheart/StudioShutterstock
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
The Value of Roflumilast Cream for Plaque Psoriasis
Deucravacitinib Approved by FDA for Treatment of Psoriasis
Plaque Psoriasis Management: Future Directions in Care
Biologic Therapy in Plaque Psoriasis: Treating During the COVID-19 Pandemic
Unmet Needs in Moderate to Severe Plaque Psoriasis Management
Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy
Plaque Psoriasis Patient Case 2: Switching Therapy at Treatment Failure
Factors in Selecting Biologic Therapy for Moderate to Severe Plaque Psoriasis
Plaque Psoriasis: Biologic Therapy Toxicity Profiles
Bimekizumab’s Potential in Moderate-to-Severe Plaque Psoriasis
Related Content
